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Beyond sample curation and basic pathologic char-
acterization, the digitized H&E-stained images of
TCGA samples remain underutilized. To highlight
this resource, we present mappings of tumor-infil-
trating lymphocytes (TILs) based on H&E images
from 13 TCGA tumor types. These TIL maps are
derived through computational staining using a con-
volutional neural network trained to classify patches
of images. Affinity propagation revealed local spatial
structure in TIL patterns and correlation with overall
survival. TIL map structural patterns were grouped
using standard histopathological parameters. These
patterns are enriched in particular T cell subpopula-
tions derived frommolecular measures. TIL densities
and spatial structure were differentially enriched
among tumor types, immune subtypes, and tumor
molecular subtypes, implying that spatial infiltrate
state could reflect particular tumor cell aberration
states. Obtaining spatial lymphocytic patterns linked
to the rich genomic characterization of TCGA sam-
ples demonstrates one use for the TCGA image
archives with insights into the tumor-immune micro-
environment.INTRODUCTION
Although studies in humans have shown that chronic inflamma-
tion can promote tumorigenesis (Trinchieri, 2012), the host
immune system is equally capable of controlling tumor growthThis is an open access article under the CC BY-Nthrough the activation of adaptive and innate immune mecha-
nisms (Galon et al., 2013). Such intra-tumoral processes are
often referred to collectively as immunoediting, where this selec-
tive pressure can result in the emergence of tumor cells that
escape immune surveillance and, ultimately, to tumor progres-
sion. At the same time, many observations suggest that high
densities of tumor-infiltrating lymphocytes (TILs) correlate with
favorable clinical outcomes (Mlecnik et al., 2011a) such as longer
disease-free survival or improved overall survival (OS) in multiple
cancer types (Angell and Galon, 2013). Recent studies further
suggest that the importance of spatial context and the nature
of cellular heterogeneity of the tumormicroenvironment, in terms
of the immune infiltrate involving the tumor center and/or inva-
sive margin, can also correlate with cancer prognosis (Fridman
et al., 2012). Prognostic factors, most notably the Immunoscore,
that quantify such spatial TIL densities in different tumor regions
have high prognostic value that can significantly supplement and
sometimes even supersede the standard TNM classification and
staging in certain settings(Galon et al., 2006; Broussard and
Disis, 2011; Mlecnik et al., 2011b). Given this and the central
role of immunotherapy treatments in contemporary cancer
care, these assessments of tumor-associated lymphocytes are
increasingly important both in the clinical assessment of pathol-
ogy slides, as well as in translational research into the role of
these lymphocytic populations.
Tissue diagnostic studies are carried out and interpreted
by pathologists for virtually all cancer patients, and the over-
whelming majority of these are stained with hematoxylin and
eosin (H&E). The TCGAPan Cancer Atlas dataset includes repre-
sentative H&E diagnostic whole-slide images (WSIs) that enable
spatial quantification and analysis of TILs and association with
the wealth of molecular characterization conducted through
the TCGA. Previously, this rich trove of imaging data has primar-
ily been used solely to qualify samples for TCGA analysis andCell Reports 23, 181–193, April 3, 2018 ª 2018 The Authors. 181
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
gleaning of some limited histopathologic parameters by expert
pathologists. Using digital pathology and digitized whole-slide
diagnostic tissue images, machine learning and deep learning
approaches can create a ‘‘Computational Stain.’’ This allows
identification and quantification of image features to formulate
higher-order relationships that go beyond simple densities
(e.g., of TILs) to explore quantitative assessments of lymphocyte
clustering patterns, as well as characterization of the inter-
relationships between TILs and tumor regions. We apply this to
the TCGA samples in a broad multi-cancer fashion. Only a few
TCGA tumor types have been explored for TIL content based
on feature extraction from histologic H&E images and in a
more limited fashion (Rutledge et al., 2013; Cancer Genome
Atlas Research Network, 2017).
Over the past 12 years, The Cancer Genome Atlas (TCGA)
has profoundly illuminated the genomic landscape of human
malignancy. More recently, it has been recognized that
genomic data derived from bulk tumor samples, which include
the tumor stromal, vascular, and immune compartments, as
well as tumor cells, can provide detailed information about
the tumor immune microenvironment. Molecular subtypes of
ovarian, melanoma, and pancreatic cancer have been defined
based on measures of immune infiltration (Cancer Genome
Atlas Research Network, 2011; Cancer Genome Atlas Network,
2015; Bailey et al., 2016), and a number of other tumors show
variation in immune gene expression by molecular subtype
(Iglesia et al., 2014, 2016; Kardos et al., 2016). Recent publica-
tions (Charoentong et al., 2017; Li et al., 2016; Rooney et al.,
2015) have presented comprehensive analyses of TCGA data
on the basis of immune content response. A recent study
(Thorsson et al., 2018) reports on a series of immunogenomic
characterizations that include assessments such as total lym-
phocytic infiltrate, immune cell type fractions, immune gene
expression signatures, HLA type and expression, neoantigen
prediction, T cell and B cell repertoire, and viral RNA expres-
sion. From these base-level results, integrative analyses were
performed to derive six immune subtypes, spanning tumor
types and subtypes. The comprehensive pairing of clinical,
sample, molecular tumor, and immune characterizations with
H&E WSIs in the TCGA is a unique resource (Cooper et al.,
2017) and offers the possibility of identifying relationships be-
tween computational staining of whole-slide images and other
measures of immune response that may in turn inform research
into immuno-oncological therapy. In this work, we characterize
spatial patterns of TILs and present relationships between TIL
patterns and immune subtypes, tumor types, immune cell frac-
tions, and patient survival, illustrating the potential of this kind
of analysis and the kinds of questions that can be explored.
For example, through integration of spatial patterns with molec-
ular TIL characterization, we found evidence for these patterns
being enriched in particular T cell populations.
This study represents an important milestone in the use of dig-
ital-pathology-based quantification as we are able to present re-
sults relating spatial and molecular tumor immune characteriza-
tions for roughly 5,000 patients with 13 cancer types. TILs and
spatial characterizations of TILs have shown significant value
in diagnostic and prognostic settings, and the ability to quantify
TILs from diagnostic tissue has proven to be demanding, expen-182 Cell Reports 23, 181–193, April 3, 2018sive, challenging to scale, and beleaguered by subjectivity. Hu-
man review of diagnostic tissue is highly effective for traditional
diagnosis but is qualitative and thus is prone to both inter- and
intra- observer variability, particularly when attempting to quan-
tify or reproducibly characterize feature-rich phenomena such as
tumor-associated lymphocytic infiltrates. The spatial character-
izations we present are high resolution, with TIL infiltration as-
sessed in whole-slide images at a 50-micron resolution, and all
TIL maps are available to the scientific community for further
exploration. The recent FDA approval (FDA News Release,
2017) of whole-slide imaging for primary diagnostic use is lead-
ing to more widespread adoption of digital whole-slide imaging.
It is widely expected that, within 5–10 years, the great majority of
new pathology slides will be digitized, thus enabling the develop-
ment and clinical adoption of various digital-pathology-based
diagnostic and prognostic biomarkers that will likely provide
decision support for traditional pathologic interpretation in the
clinical setting.
RESULTS
Generating Maps of Tumor-Infiltrating Lymphocytes
using Convolutional Neural Networks
In order to accurately generate maps of tumor-infiltrating lym-
phocytes (TIL Maps) from digitized H&E stained tissue speci-
mens, we developed a comprehensive methodology and
accompanying interactive tools. This methodology is termed
Computational Staining and employs deep learning methods to
analyze images and tools to incorporate expert feedback into
the deep learning models. Such iterative feedback results in
the improvement of the overall accuracy of TIL Maps. Key high-
lights and the validation strategy for Computational Staining
are presented here, with further details provided in the Method
Details.
Computational Staining uses convolutional neural networks
(CNNs) to identify lymphocyte-infiltrated regions in digitized
H&E stained tissue specimens. The CNN is a supervised deep
learning method that has been successfully applied in a large
number of image analysis problems (Ciresxan et al., 2013; Huang
et al., 2016; Xie et al., 2015a,2015b;Wang et al., 2016; Sirinukun-
wattana et al., 2016; Bayramoglu and Heikkila, 2016; Su et al.,
2015; Hou et al., 2016a; Murthy et al., 2017;Chen et al., 2017;
Xu and Huang, 2016). A CNN first uses a set of training data to
learn a classification (or predictive) model in the training phase.
The resulting trained model is then used to classify new data
elements in a prediction phase. Deep-learning-based automatic
analysis methods generally require large annotated datasets.
Many state-of-the-art methods employ semi-supervised training
strategies to boost trained model performance using unlabeled
data (Ranzato et al., 2006; Masci et al., 2011; Bayramoglu and
Heikkila, 2016; Xu andHuang, 2016; Su et al., 2015). They (1) pre-
train an autoencoder for unsupervised representation learning;
(2) construct a CNN from the pretrained autoencoder; and
(3) fine-tune the constructed CNN for supervised classification.
One can train the unsupervised autoencoder on image patches
with the object to be classified (e.g., nucleus) in the center of
each patch (Hou et al., 2016a; Murthy et al., 2017) in order to
Figure 1. Workflow for Training, Model Development, and Subsequent Generation of TIL Maps
Top: for training and developing CNN models, a pathologist reviews images and marks regions with lymphocytes and necrosis. These training data are then
broken down into patches that are then fed into a training stage to train CNNs for lymphocyte and necrosis detection. A pathologist periodically reviews the results
for accuracy and corrects the prediction. This results in a pair of Trained CNNs. Bottom: these trained CNNs are then used on the full set of 5,455 images
from 13 cancer types to generate TIL maps. During TIL map generation, a probability map for TILs is generated from each image. These probabilities are then
reviewed and lymphocyte selection thresholds are established using a selective sampling strategy (further information in Method Details). These thresholds are
then used to obtain the final TIL maps. See also Figure S1 and Tables S1 and S2.capture the visual variance of the object more accurately. This
method, however, requires a separate object detection step.
Instead of tuning the detection and classification modules sepa-
rately, recent studies (Graves and Jaitly, 2014; Ren et al., 2015;
Redmon et al., 2016; Kokkinos 2017) have developed CNNs to
perform these tasks in a unified but fully supervised pipeline.
Our methodology uses two CNNs: a lymphocyte infiltration
classification CNN (lymphocyte CNN) and a necrosis segmenta-
tion CNN (necrosis CNN). The lymphocyte CNN categorizes tiny
patches of an input image into those with lymphocyte infiltration
and those without. It is a semi-supervised CNN, initialized by an
unsupervised convolutional autoencoder (CAE). The necrosis
CNN segments the regions of necrosis and is designed to
eliminate false positives from necrotic regions where nuclei
may have characteristics similar to those in lymphocyte-infil-
trated regions. Details about the two CNNs are shown in Fig-
ure S1A and described in the Method Details.
Figure 1 illustrates both the training and model development
phase of our methodology (top half of the figure) and the use of
the trained model to generate TIL Maps (bottom half of the
figure). The CNN training and model development phase starts
with expert pathologists reviewing a set of images and marking
regions of lymphocytes and necrosis. The lymphocyte and ne-
crosis regions are then subdivided into tiny patches to create
the initial training dataset. Training with patches rather than
with individual regions and cells is done for computational effi-
ciency. The lymphocyte CNN is trained with 50 3 50 mm2
patches (equivalent to 100 3 100 square pixel patches in tissue
images acquired at 203magnification level) from WSIs. The ne-crosis CNN is trained with larger patches of size 5003 500 mm2,
as more contextual information results in superior prediction of
patches being necrotic. The initial training step is followed by
an iterative cycle of review and refinement steps to improve
the prediction accuracy of the lymphocyte CNN. This prediction
step generates a probability value of lymphocyte infiltration for
each patch in the images. The patch-level predictions for an im-
age are combined and represented to pathologists as a heatmap
for review and visual editing using our TIL-Map editor tool. The
pathologists refine the CNN predictions for an image by first ad-
justing the probability value threshold (which globally updates
the labels of the patches in the image; if the probability value
of a patch exceeds the adjusted threshold, the patch is labeled
a TIL patch) and then manually editing the heatmap to correct
prediction errors for individual or groups of patches. At the end
of the editing step, the updated heatmaps are processed to
augment the training dataset. The lymphocyte CNN is re-trained
with the updated training dataset. This iterative process con-
tinues until adequate prediction accuracy is achieved, as deter-
mined by the pathologist feedback. The necrosis CNN was re-
trained only once in this study, because it achieved sufficient
prediction accuracy. The training and re-training steps of both
CNNs involve cross-validation to assess prediction performance
and avoid overfitting (Hou et al., 2017). See the Method Details
for an in-depth description of this process.
The trained models are used on test datasets (bottom half of
Figure 1). In this work, we applied ourmethod to 5,455 diagnostic
H&E WSIs from 13 TCGA tumor types in which lymphocytes are
known to be present. See Additional Resources for listing andCell Reports 23, 181–193, April 3, 2018 183
Figure 2. Assessment of TIL Prediction
(A) Receiver Operating Characteristic depicting performance of CNN. Applied
to TCGA lung adenocarcinoma patches. The current method is compared with
a popular CNN called VGG16 (see main text description).
(B) Comparison of TIL scores of super-patches between pathologists and
computational stain. x axis: median scores from three pathologists assessing
400 super-patches as having low,medium, or high lymphocyte infiltrate. y axis:
scores from computational staining, on a scale from 0 to 64.acronyms. We included uveal melanoma (UVM) as one of the
13 cancer types essentially as a type of negative control (Fig-
ure S3A), since it has the fewest immune cells among TCGA
tumors (Thorsson et al., 2018). Tumor types were selected to
represent a range of known positive involvement of lymphocytes
and immunogenicity from literature and from molecular esti-
mates of lymphocyte content. Each image was partitioned into
patches of 50 3 50 mm2 and each patch was classified by
the CNNs. TIL maps were successfully generated (see Fig-
ure S1C and Table S2) for 5,202 TCGA tumor images from
4,759 individual participants in the 13 tumor types. 253 images184 Cell Reports 23, 181–193, April 3, 2018(4.6%) did not yield TIL maps because of low image quality or
low prediction accuracy or because the images were duplicates
(see Figure S1C).
We assessed the performance of our approach in two comple-
mentary, yet orthogonal ways. The first assessment method,
described in Zhao et al. (2017), compares performance predic-
tion of our method with that of a popular and widely used
CNN—called VGG16 (Simonyan and Zisserman, 2014)—using
a set of WSIs from TCGA lung adenocarcinoma (LUAD) cases.
The training set of the lymphocyte CNN consisted of 20,876
patches. Each patch usually contains 0 to 30 nuclei and was an-
notated by a pathologist as lymphocyte infiltrated or not lympho-
cyte infiltrated. The training set of the necrosis segmentation
CNN consisted of 1,800 patches. Each patch was annotated
with a necrosis region mask segmented by a pathologist. We
sampled 2,480 patches to create the test dataset. The ROC
curve shows that our approach slightly outperforms VGG16 by
3.1% with respect to the area under ROC curve (AUROC) metric
(Figure 2A). We also performed direct comparison of TIL patch
assignments by the Computational Staining pipeline with those
by experienced pathologists by scoring 8 3 8 ‘‘super-patches’’
for TIL content. Three pathologists assessed 400 super-patches
as having low, medium, or high TIL content, while machine-
derived scores were assigned for the patch by counting TIL-pos-
itive patches (thus ranging from 0 to 64). Consistency was high
among each of the pathologists (> 80%), as assessed by re-
scoring of 100 super-patches. As seen in Figure 2B, the median
machine-derived score is quite distinct between the three ordinal
bins. This is evidenced in strong correlation as assessed by the
polyserial coefficient (Drasgow, 2014), designed for comparing
ordinal with continuous values (0.36 with 95% CI [0.27,0.45],
p value = 5.2 3 1015, R package polycor).
Assessment and Correlates of TIL Spatial Fraction
Spatial Fraction of TILs
The spatial fraction of TILs was estimated as the fraction of TIL-
positive patches among the total number of patches identified on
the tissue sample. A wide range in spatial infiltrate is seen among
the TCGA tumor types (Figure 3A and Table S1), with high infil-
trates in gastric cancer (STAD) with amean of 14.6%, rectal can-
cer (READ) at 13.0%, squamous cell carcinoma in the lung
(LUSC) at 11.6%, while uveal melanoma (UVM) has only 1% esti-
mated TIL fraction, consistent with its inclusion as negative con-
trol (Figure S3A).Wide differences are also seen grouping tumors
by the nature of the immune response, according to a recent im-
mune characterization of all TCGA tumors (Thorsson et al.,
2018)(Figure 3B). The most immunologically active immune sub-
types (e.g., C1, C2) tend to have the greatest spatial infiltration of
lymphocytes. Within documented TCGA subtypes, which are
typically characterized by specific molecular changes in tumor
cells, strong differences are also seen (Figure S2A). EBV-positive
gastric cancer is particularly rich in TILs, with an average of 25%
of spatial regions infiltrated by TILs (Figure 3C). The lung squa-
mous secretory subtype (Wilkerson et al., 2010) is also particu-
larly rich in infiltrate (17%, Figure 3D) as is the mutation-rich
POLE subtype of endometrial cancer. Among breast cancer tu-
mors, the basal subtype has the greatest infiltrate (Figure 3E),
consistent with what has been observed in other studies (Iglesia
Figure 3. TIL Fraction by Tumor Category
(A–E) Percent TIL fraction, the proportion of TIL-positive patches within a TIL map, is shown by various categorizations of TCGA tumor samples. Each plotted
point represents a tumor sample for (A) 13 TCGA tumor types (4,612 cases), (B) six subtypes characterized by differences in the nature of the overall immune
response (Thorsson et al., 2018) (C5 has very few samples here), (C) gastrointestinal adenocarcinoma subtypes, (D) lung squamous cell carcinoma subtypes, and
(E) breast adenocarcinoma subtypes. See also Figure S2.et al., 2014). Taken together, these data show that the nature of
the infiltrate has strong ties to aspects of the tumor microenvi-
ronment and that the nature of the infiltrate may be reflective of
particular molecular aberration states of tumor cells.
The spatial fraction of TILs was compared with molecular es-
timates of TIL content from molecular genomics assays (Thors-
son et al., 2018). The molecular estimate of TIL fraction is ob-
tained by multiplying an estimate of the overall leukocyte
fraction, based on DNA methylation arrays, with an estimate
of the lymphocyte proportion within the immune compartment
obtained by applying CIBERSORT (Newman et al., 2015) to
RNA sequencing data. Good, albeit imperfect, agreement is
seen between the imaging and molecular estimates (Figure 4A),
with Spearman correlation values ranging from 0.20 to 0.45 for
the most part accompanied by highly significant p values, and
with UVM, the negative control, showing no correlation. The
reasons for the differences between the molecular estimates
and spatial TIL fraction include: (1) molecular data are extracted
from a fresh frozen tissue section in proximity to the formalin-
fixed paraffin-embedded (FFPE) sample used to generate the
diagnostic H&E image, but the exact spatial relation is unknown;
(2) the molecular estimate is proportional to the number
of lymphocytes, whereas the spatial fraction of TILs is estimated
by tissue area; (3) the spatial analysis and TIL fraction
are an assessment of lymphocyte-infiltrated tissue that can
also include non-tumor regions on the diagnostic slides; and(4) the molecular quantification is obtained from frozen sections
that are highly enriched for tumor as a criterion for project inclu-
sion. We further examined the outlier cases (see Figures 4B and
4C) having high levels of discordance between molecular and
spatial image-derived TIL estimates for several tumor types,
including BRCA, SKCM, LUAD, LUSC, STAD, and READ. We
determined that spatial TILs in non-tumor regions appeared to
play a major explanatory role (Figures S3B and S3C). Attempts
to exclude such areas by manual negative masking and/or
CNN-based automation for tumor recognition will be included
in future efforts in order to reduce the discordance between
the molecular estimates from samples that are highly enriched
for tumor and the spatial TIL estimates derived from diagnostic
H&E images.
Automated Assessment of Local Structures in the TIL
Infiltrate and Association with Molecular and Clinical
Readouts
Local Spatial Structure of the Immune Infiltrate
A unique feature of imaging data is the ability to go beyond total
lymphocytic infiltrate load to the assessment of patterns of lym-
phocytic infiltration. To identify such patterns, we first used affin-
ity propagation (FreyandDueck, 2007) to findspatially connected
and coherent regions (clusters) of TIL image patches (APCluster
R package; Bodenhofer et al., 2011). Examples of H&E images,
TIL maps, and clusters are shown in Figures 5A–5D for selectedCell Reports 23, 181–193, April 3, 2018 185
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Figure 4. Comparison of TIL Proportion from Imaging and Molecular Estimates
(A) Spearman correlation coefficients and p values for comparison of TIL fraction from spatial estimates of TIL maps and molecular estimates of TIL fraction from
processing of cancer genomics data using deconvolution methods (see main text).
(B) Each point represents a breast adenocarcinoma tumor sample, with the value of TIL fraction from TIL maps (x axis) and from molecular estimates (y axis).
(C) As in B for 12 additional TCGA tumor types. See also Figure S3 and the companion manuscript (Thorsson et al., 2018).cases exemplifying sparse and dense lymphocyte infiltrates. For
each slide, the resulting cluster pattern was characterized using
measures for simple count and extent statistics but also by
clustering indices, which assess more complex characteristics
such as cluster shape. Summary measures include the number
of clustersNcluster, themeannumber of TIL patches in the clusters
NP, the mean of the within-cluster dispersion WCD, and the
meanof cluster spatial extentsCE (seeFigure5E,MethodDetails,
and Table S1). In terms of TIL patch distances to a given cluster
center, the dispersion is related to their variance, while spatial
extent is akin to the maximal distance. Ncluster ranged from 2 to
46 over the entire cohort (4,480 cases, excluding non-tumor
slides), with a median of 12, and the mean cluster membership
was 293 TIL patches. We calculated the clustering indices of
Ball and Hall (1965), Banfield and Raftery (1993), the C index,
and thedeterminant ratio index, as implemented in theRpackage
clusterCrit (see Method Details and Table S1). The Ball-Hall
index is the mean of the dispersion through all of the clusters,
equivalent to the mean of the squared distances of the points of186 Cell Reports 23, 181–193, April 3, 2018the cluster with respect to its center. In our data, the Ball-Hall in-
dex is correlated (rSpearman = 0.95) with the mean cluster extent,
CE. The Banfield-Raftery index is the weighted sum of the loga-
rithmsof themeancluster dispersion,which inour data correlates
with Ncluster (rSpearman = 0.95). We found similarity among
several of the various scores (Figure S4A), including overall
trending of some clustering indices to simpler measures such
as Ncluster and TIL fraction. The C index is derived from pairwise
distances and does not scale with any of the simpler measures.
Values of these scores for the cases depicted in Figures 5A–5D
are shown in Figure 5E. Clustering indices vary widely over
slides, as illustrated in Figure 6A for the Ball-Hall index. Tumors
with relatively high values of this index, such as BRCA and
PRAD, are not among those with highest overall infiltrate (Fig-
ure 3A). Since the Ball-Hall index scales with approximately
cluster extent, this implies that, in some of these tumor types
of moderate infiltrate mass, TIL clusters of relatively large
spatial extent are formed. In summary, this implies that, in some
tumor types, local clustering of TILs may be a more distinctive
Figure 5. Examples of TIL Map Structural
Patterns
(A–D) Four cases representing different degrees of
lymphocyte infiltration. Each example is labeled by
TCGA participant barcode and has the following
three panels. Left: H&E diagnostic image at low
magnification with tumor regions circled in yellow;
middle: TIL map; red represents a positive TIL
patch, blue represents a tissue region with no TIL
patch, while black represents no tissue; right: di-
agrams of clusters of TIL patches derived from the
affinity propagation clustering of the TIL patches.
Line segments connect cluster members with a
central representative for each cluster, and colors
are arbitrarily assigned to aid visual separation of
clusters.
(E) TIL map, cluster statistics, and global patterns
for the four examples in A–D. Each column repre-
sents one way to characterize the TIL map, ranging
from simple measures such as TIL count and
density to more complex ones characterizing de-
tails of cluster properties and image patterns (see
main text). See also Table S2.feature than overall TIL infiltrate, in comparison with other tumor
types.
Correlates of Local TIL Spatial Structure with Survival
We examined the extent to which TIL fraction might impact
overall survival and the extent to which spatial characteristics
of the tumor microenvironment—beyond overall densities—
may provide additional predictive power of outcome. We
used Cox regression, accounting for age and gender as addi-
tional clinical covariates to perform survival analysis. In order
to mitigate possible problems in interpretation due to the
inherent correlation between some clustering indices and the
TIL densities, we used linear regression to obtain adjusted clus-
ter indices by computing residuals with respect to TIL density
(see Method Details). p values were obtained for four adjusted
indices and 13 tumor types, which were then adjusted for mul-
tiple testing using the Benjamini-Hochberg procedure. Five as-
sociations between cluster index and outcome were significant
(at p < 0.05) and are shown in Figure 6B. Interestingly, the
various indices were significant across different tumor types.
Examples of Kaplan-Meier curves for median-split clustering
indices are shown in Figures 6C (BRCA) and 6D (SKCM). In
SKCM, increased Banfield Raftery-index (‘‘cluster count’’) as-
sociates with superior survival, while in BRCA increased Ball-CHall index (‘‘cluster extent’’) associates
with inferior survival, both adjusted
for overall TIL density. Of interest,
checkpoint inhibition immunotherapy
has been successfully applied to mela-
noma, while breast cancer tumors have
generally been unresponsive to check-
point blockade therapy. The association
of structure with survival, as evidenced
by less favorable survival in tumors with
elevated adjusted Ball-Hall index (‘‘clus-
ter extent’’) could be worthy of furtherinvestigation as a stratification factor for patient tumors in clin-
ical studies of response.
Characterization of Overall TIL Map Structural Patterns
and Association with Molecular Estimates
We undertook further characterization of TIL spatial structure,
looking beyond local spatial structures toward a global structure
classification that reflects standard descriptions in current use
by practicing pathologists. We incorporated qualitative and
semiquantitative descriptions and scoring of the TIL map struc-
tural patterns in the combined intra-tumoral and peri-tumoral
regions (collectively referred to as ‘‘tumor’’) that are grossly
defined by the corresponding H&E-stained whole-slide images.
As seen in the recommendations from of the International TILs
Working Group (Salgado et al., 2015), International Immuno-
oncology Biomarkers Working Group (Hendry et al., 2017a,
2017b), and the prognostic descriptions used to characterize
TILs in cutaneousmelanoma (Crowson et al., 2006), pathologists
classify patterns within the TIL maps in both the intratumoral and
peritumoral regions. Correspondingly, patterns in the 5,202 TIL
maps were visually assigned by a pathologist into one of five
categories: ‘‘Brisk, diffuse’’ for diffusely infiltrative TILs scattered
throughout at least 30% of the area of the tumor (1,856 cases);ell Reports 23, 181–193, April 3, 2018 187
Figure 6. Associations of TIL Local Spatial Structure with Cancer Type and Survival
Associations are shown with cluster indices, which summarize properties of clusters derived from affinity propagation clusters of the TIL map—properties that
provide details on local structure beyond simple densities.
(A) Ball-Hall cluster indices for all slide images considered in the study. The Ball-Hall index is a particular clustering index, summarizing the mean, through all the
clusters, of their mean dispersion and is equivalent to the mean of the squared distances of the points of the cluster with respect to its center. In our data, the Ball-
Hall index is correlated (rSpearman = 0.95) with the mean cluster extent, CE.
(B) Table of significant associations between TIL fraction-adjusted cluster indices and overall survival based on Cox regression, accounting for age and gender as
additional clinical covariates.
(C) Overall survival for median-stratified TIL fraction-adjusted Ball-Hall index in breast cancer. Significance test p value is shown in the lower left.
(D) Same as C but for adjusted Banfield-Raftery index in skin cutaneous melanoma. The Banfield-Raftery index is the weighted sum of the logarithms of the mean
cluster dispersion and, in our data, often correlates with the number of clusters. See also Figure S4.‘‘Brisk, band-like’’ for immune responses forming band-like
boundaries bordering the tumor at its periphery (1,185); ‘‘Non-
brisk, multi-focal’’ for loosely scattered TILs present in less
than 30% but more than 5% of the area of the tumor (1,083);
‘‘Non-brisk, focal’’ for TILs scattered throughout less than 5%
but greater than 1% of the area of the tumor (874); and finally
‘‘None’’ in 143 cases where few TILs were present involving
1% or less of the area of the tumor (see Method Details). TIL
maps with corresponding H&E images with insufficient or no
grossly identifiable tumor at low magnification were designated
as indeterminate (61). The examples in Figures 5A–5D are cate-
gorized as follows: Figure 5A, TCGA-33-AASL Brisk, diffuse
pattern in a case of squamous cell carcinoma of the lung
showing a relatively strong immune infiltrate within the tumor;
Figure 5B, TCGA-D3-A2JF Brisk, band-like pattern in a case of
cutaneous melanoma showing immune infiltrates forming
boundaries bordering the tumor at its periphery and < 30%
TILs in the intra-tumoral component; Figure 5C, TCGA-E9-
A22H Non-brisk, multi-focal pattern in a case of invasive ductal
carcinoma of the breast showing a weak immune response
with loosely scattered TILs; Figure 5D, TCGA-EW-A1OX Non-
brisk, focal pattern in a case of invasive ductal carcinoma of
the breast showing a very weak immune response in a focal
area (categories also listed in final column of Figure 5E).188 Cell Reports 23, 181–193, April 3, 2018The TIL map global patterns are not distributed in an equal
manner among TCGA tumor types. Figure 7A shows the ratio
of observed counts over those expected randomly. BRCA is en-
riched in the ‘‘Non-brisk, focal’’ phenotype (374 observed; 166
expected; p value < 3 3 1016, Fisher’s exact test, Benjamini-
Hochberg adjusted). PAAD is enriched in the ‘‘Non-brisk, multi-
focal’’ phenotype (70 observed; 36 expected; p = 8 3 108), as
is PRAD (151; 70; p < 3 3 1016). The ‘‘Brisk, band-like’’ pheno-
type is most enriched in SKCM (134; 86; 33 107) and very rare
in PAAD (7; 37; 2 3 109) and PRAD, whereas ‘‘Brisk, diffuse’’ is
more prevalent in STAD, READ, and CESC (p = 2 3 1013,
4 3 106, and 3 3 1010, respectively). Some TCGA subtypes
also show enrichment in particular patterns (Figure S5A). For
example, EBV-positive GI cancers are enriched in the ‘‘Brisk,
diffuse’’ phenotype (14; 5; 6 3 103). Differences are also seen
among immune subtypes (Figure S5B) defined in the TCGA
pan-immune analysis (Thorsson et al., 2018), where the C4 sub-
type is enriched in the ‘‘Non-brisk, focal’’ (82; 44; 63 108). This
is noteworthy, as subtype C4 is relatively richer in cells of the
monocyte/macrophage lineage, which may play a role in sculpt-
ing the TME as evidenced in these patterns. Interestingly, the im-
mune subtype C3, which tends to have good prognosis overall,
has relatively few ‘‘Brisk band-like’’ structures (59; 162; < 3 3
1016), perhaps reflective of the more moderate and tempered
AB
Figure 7. Association of Spatial Structural
Patternswith Tumor Type andCell Fractions
(A) Each row corresponds to one of four spatial
structure patterns, assigned in a manner consis-
tent with the descriptions currently used to
characterize the nature of the immune infiltrate
in standard histopathological examinations, and
each column is a TCGA tumor types. The values
shown are the sample count for each tumor type
and spatial structure pattern, divided by the counts
expected by chance. The ratio of observed to ex-
pected co-membership counts is shown on a color
scale, where the largest ratios are in red, values
near unity as yellow, and blue represents fewer
than expected counts.
(B) Estimates of the proportion of CD4, CD8, NK
cells, and B cells were segregated by spatial
structure patterns and averaged. Bars show the
proportion within each structural pattern. These
proportions are estimated using molecular data of
the TCGA. See also Figure S5.immune response or productive infiltration of lymphocytes into
tumor regions. C2, which has relatively poor outcome, is some-
what richer in ‘‘Brisk’’ phenotypes, consistent with expectations
that the relatively large degree of lymphocytic infiltrates are not
adequately controlling tumor growth in this class of tumors. In
summary, the global structural patterns show associations with
distinct immune responses that can be either particular to sub-
types, or shared across multiple tumor types, and may play a
role in the determining the nature of the immune responses in
the corresponding tumor microenvironments.
We also examined whether there was evidence of differences
in the types of lymphocytes, such as signatures for CD4 T cells,
CD8 T cells, B cells, and NK cells, represented in each pheno-
type. These cells cannot be distinguished by the H&E image
analysis, but estimates of their proportions are available through
analysis of the molecular data (Thorsson et al., 2018 andMethod
Details). Averaging these values within structural patterns, we
see emerging relationships (Figures 7B and S5C), where ‘‘Brisk’’
phenotypes have a higher proportion of CD8 T cells than those
seen in the ‘‘Non-Brisk’’ phenotypes (mean 13.2% versus
10.7%, p value < 2.2 3 1016, Mann–Whitney–Wilcoxon test).
Correspondingly, ‘‘Non-Brisk’’ phenotypes tend to have a
slightly greater proportion of CD4 T cells (p = 0.03). Thus, by
combining molecular estimates of cell proportion with structural
analysis of imagining data, we see evidence that particular T cell
subsets may play distinct roles in the formation of global struc-
tural patterns.
DISCUSSION
The scanned archival H&E archives of the TCGA are a rich but
quite underutilized resource within this project. In effect, it is a
largely ignored source of data that has only been manually and
sporadically mined and awaits more systematic characterizationCusing the variety of analytic tools and an-
alyses currently available. These images
have generally been used solely to ensurethe correct diagnosis, and panels of expert pathologists also
used the images to glean other variables such as mitotic activity,
tumor grade, and histologic subtypes for some of the TCGA
marker papers. The recently published sarcoma TCGA marker
paper utilized automated feature extraction of nuclear properties
for correlation with copy number load and genomic doubling
(Cancer GenomeAtlas Research Network, 2017). The cutaneous
melanoma TCGA marker paper used a visual inspection of
expert pathologists to assess the degree and pattern of lympho-
cytes in the frozen section images of the tissue going to the mo-
lecular platforms to correlate with other genomic and proteomic
assessments of lymphocytic infiltrate and also directly with clin-
ical outcome (Cancer Genome Atlas Network, 2015). This was a
manual process done by expert pathologists, and there was no
attempt at automation. The efforts presented in this present
work represent an initial attempt to systematically employ auto-
mated image processing to assess lymphocytic infiltrates across
multiple TCGA tumor types for correlation with genomic and epi-
genomic assessments of lymphocytic infiltrates, as well as clin-
ical outcome. Our sincere hope is that this early attempt to
exploit this remarkable TCGA resource of associated scanned
histologic images will spur others to similar approaches.
We report a scalable and cost-effective methodology for
computational staining to extract and characterize lymphocytes
and lymphocytic infiltrates in intra-tumoral, peri-tumoral, and
adjacent stromal regions. In comparing TIL fraction identified
via molecular methods to TIL maps derived from digital image
analyses of H&E images, we found good but certainly not perfect
agreement. Several factors may be contributing. First, perfect
agreement is not expected, since the estimates being compared
are not of the same quantity or source. Indeed, the molecular
estimates are analogous to cell count ratios, and the image frac-
tions correspond to the proportion of spatial areas that contain
TILs. Second, the exact spatial relation between the sampleell Reports 23, 181–193, April 3, 2018 189
from which the molecular data is extracted (between the so-
called frozen tissue top-section and bottom-section) and the
diagnostic images from the FFPE examples used to generate
the diagnostic H&E slides is not known. The TILmaps are derived
from high-quality scanned diagnostic FFPE H&E slides from tis-
sue samples in an adjacent or possibly a more distant portion of
the tumor relative to where the top and bottom frozen sections
are sampled. Unfortunately, the frozen section images are not
of a quality that permits robust features extraction. Even though
some degree of correlation is certainly expected since TIL status
is often a property of the tumor as a whole, upon further evalua-
tion, we observed regional differences in a subset of samples
within the overall assessment. These differences are largely ex-
plained by the effect of spatial TILs in non-tumor regions in the
diagnostic H&E images, which appeared quite different than
the spatial TILs in the frozen section samples used for molecular
TIL estimates.
Integrated analysis of TIL maps and molecular data reveals
patterns and associations that can improve our understanding
of the tumor microenvironment, and we illustrate some emerging
relationships in this work. Both local patterns and overall struc-
tural patterns are differentially represented among tumor types,
immune subtypes, and tumor molecular subtypes, the latter of
which are typically driven by particular molecular alterations
in the tumor cell compartment. This implies that the nature of
spatial lymphocytic infiltrate state may be reflective of particular
aberration states of tumor cells. In some tumor types (such as
PAAD and PRAD), local clustering of TILs may be amore distinc-
tive feature than overall TIL infiltrate, as compared with other tu-
mor types. Structural patterns are further seen to be associated
with survival, implying that the nature and effectiveness of im-
mune response is encoded in patterns that may be assessable
at the time of tumor diagnosis. For example, in breast cancer,
less favorable survival in tumors with elevated adjusted Ball-
Hall index (‘‘cluster extent’’) might be worth further investigation
in terms of stratification of patient tumors in clinical studies of
response. Overall structural patterns show associations with im-
mune responses that are shared acrossmultiple tumor types and
may thus play a role in the determining the nature of those re-
sponses. For example, tumors with C2 immune subtypes, which
tend to have relatively poor outcome, are somewhat richer in
‘‘Brisk’’ phenotypes, consistent with expectations that the rela-
tively large degree of lymphocytic infiltrates are not adequately
controlling tumor growth in these tissues. The immune subtype
C3, which tends to have good prognosis overall, has fewer
‘‘Brisk band-like’’ structures, perhaps reflective of the more
moderate and tempered immune response, or productive infil-
tration of lymphocytes into tumor regions. In contrast, tumors
with the C4 immune subtype, which tends to be rich in cells of
the monocyte/macrophage lineage, tend to have more ‘‘Non-
brisk, focal’’ structures that may play a role in sculpting the
TME as evidenced in these patterns. Finally, these patterns are
enriched in particular T cell subpopulations as derived from
molecular measures. For example, ‘‘Brisk’’ phenotypes have a
higher proportion of CD8 T cells than those seen in the ‘‘Non-
Brisk’’ phenotypes.
A number of factors can contribute to cancer patient outcome.
In our analyses, we attempted to control for age and sex, but190 Cell Reports 23, 181–193, April 3, 2018other factors such as tumor grade could affect the presence
or function of tumor-infiltrating lymphocytes. Grade is more
challenging to control for across tumor types, as some are not
graded such as melanoma while others such as breast and
prostate cancer have very different grading systems that are
challenging to compare rigorously. We readily accept that tumor
grade and potentially other factors could influence lymphocytic
infiltrates in both degree and pattern.
These analyses and early results demonstrate the vast poten-
tial of combining analysis of spatial structure with advanced
genomics and molecular assessment, as the TIL information is
being provided in the context of tumor molecular data wide
in detail and in scope. The TCGA molecular datasets and the
characterizations performed on them through the work of the
PanCancer Atlas consortium, including those on the tumor-
immune interface and the tumor microenvironment, provide an
extraordinarily rich source of correlative molecular information
for our discovered TIL patterns.
H&E imaging is performed routinely in labs throughout the
world as a component of tumor diagnostics. Methods for ex-
tracting information on TILs from H&E scanned images are
potentially of enormous research validity and possible clinical
applicability—hundreds of thousands of whole-slide images
exist in public repositories, in hospital system databases, and
many more will be generated for years to come. In a clinical
setting, rapid and automated identification of the degree and na-
ture of TIL infiltrate might be instrumental in determining whether
options for immunotherapy should be explored or whether more
detailed and costly immune diagnostics should be introduced.
Indeed, our approach might also complement immunopheno-
typing data, and the patterns of immune infiltration assessed
by pathologists are already widely employed in the standard
clinical reports of primary melanomas as a prognostic factor.
Applying methods like those we present here could also allow
for very incisive research at very reasonable price points and
levels of convenience. These kinds of analyses can only improve
with more detailed molecular-marker-based assays such as
immunohistochemistry, which are not currently applied in most
standard clinical settings due to lack of clinical necessity. Since
the TCGA cohorts often predate the broad clinical application of
effective immunotherapy such as checkpoint inhibitors and
contain little data regarding outcomes with such therapy, asso-
ciation of our TIL estimates and derived infiltration patterns await
more appropriate datasets to test associations.
We believe our CNN-derived TIL mapping provides a repro-
ducible and robust tool for the assessment of these lymphocytic
infiltrates. The ability to assess this tumor feature is rapidly
becoming vital to both clinical diagnosis and translational
research for onco-immunologic cancer care. These results
show that this approach correlates with molecular assessments
of TILs generated by the molecular platforms of the TCGA and
can also correlates with clinical outcome for certain tumor types.
Importantly, this study shows the value of feature extraction from
the information-rich resource of the scanned H&E image archive
of the TCGA. This resource has not been exploited to the degree
of the other TCGA molecular and clinical outcome resource and
clearly not to the degree it can support. This present study dem-
onstrates value that can be added by careful examination of this
rich resource, and it is our sincere hope that others will soon
explore the many facets of these imaging data.
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Human Subjects
A total of 4612 participants were included in this study. This study contained both males and females, with inclusions of genders
dependent on tumor types. There were 2655 females and 1957 males. TCGA’s goal was to characterize adult human tumors; there-
fore, the vastmajority of participants were over the age of 18. However, one participant under the age of 18 had tissue submitted prior
to clinical data. Age was missing for 40 participants. The range of ages was 15–90 (maximum set to 90 for protection of human sub-
jects) with a median age of diagnosis of 63 years of age. Institutional review boards at each tissue source site reviewed protocols and
consent documentation and approved submission of cases to TCGA. Detailed clinical, pathologic and molecular characterization of
these participants, as well as inclusion criteria and quality control procedures have been previously published for each of the indi-
vidual TGCA cancer types.
Sample Inclusion Criteria
Surgical resection of biopsy bio-specimens were collected from patients that had not received prior treatment for their disease
(ablation, chemotherapy, or radiotherapy). Institutional review boards at each tissue source site reviewed protocols and consent
documentation and approved submission of cases to TCGA. Cases were staged according to the American Joint Committee on
Cancer (AJCC). Each frozen primary tumor specimen had a companion normal tissue specimen (blood or blood components,
including DNA extracted at the tissue source site). Adjacent tissue was submitted for some cases. Specimens were shipped over-
night using a cryoport that maintained an average temperature of less than 180C.
Pathology quality control was performed on each tumor and normal tissue (if available) specimen from either a frozen section slide
prepared by the BCR or from a frozen section slide prepared by the Tissue Source Site (TSS). Hematoxylin and eosin (H&E) stained
sections from each sample were subjected to independent pathology review to confirm that the tumor specimen was histologically
consistent with the allowable hepatocellular carcinomas and the adjacent tissue specimen contained no tumor cells. Adjacent tissue
with cirrhotic changes was not acceptable as a germline control, but was characterized if accompanied by DNA from a patient-
matched blood specimen. The percent tumor nuclei, percent necrosis, and other pathology annotations were also assessed. Tumor
samples withR 60% tumor nuclei and% 20% or less necrosis were submitted for nucleic acid extraction.e1 Cell Reports 23, 181–193.e1–e7, April 3, 2018
TCGA Tumor Types Used in this Study
BLCA Bladder urothelial carcinoma
BRCA Breast invasive carcinoma
CESC Cervical squamous cell carcinoma and endocervical adenocarcinoma
COAD Colon adenocarcinoma
LUAD Lung adenocarcinoma
LUSC Lung squamous cell carcinoma
PAAD Pancreatic adenocarcinoma
PRAD Prostate adenocarcinoma
READ Rectum adenocarcinoma
SKCM Skin Cutaneous Melanoma
STAD Stomach adenocarcinoma
UCEC Uterine Corpus Endometrial Carcinoma
UVM Uveal Melanoma
METHOD DETAILS
Image and Molecular Data Acquisition
Whole-slide tissue images were obtained from the public TCGA Data Portal (images are currently available from the Genomic Data
Commons (GDC) Legacy Archive, following the deprecation of the TCGA Data Portal). Our study uses the diagnostic images, with
some images from frozen tissue specimens used in the analysis of discrepancies with molecular estimates. The images were down-
loaded in the native image format, Aperio SVS files, in which they had been scanned. An SVS file stores an image in multiple reso-
lutions, including the highest resolution the image data was captured; for example in an image that is acquired at a 40xmagnification,
each pixel is 0.25 3 0.25 microns. An open source library called OpenSlide (http://openslide.org/formats/aperio/) was used to
extract the highest resolution image data for our study. 5455 diagnostic slides were analyzed the 13 TCGA tumor types in the study.
Clinical and molecular data were obtained from processed and quality controlled files of the PanCancer Atlas consortium,
available at (https://gdc.cancer.gov/about-data/publications/pancanatlas).
Convolutional Neural Networks for TIL Maps
Our overall methodology consists of two CNNs (a lymphocyte-infiltrated classification CNN (lymphocyte CNN) and a necrosis
segmentation CNN), as well as mechanisms for capturing and incorporating feedback from pathologists, to evaluate and refine a
generated Tumor-Infiltrating Lymphocyte (TIL) Map.
As is presented in the Results section, the lymphocyte CNN classifies image patches. Only foreground patches are processed
and classified. To determine if a patch is a foreground patch, our analysis pipeline checks if the patch has enough tissue using
the variance in Red, Green and Blue channels of the patch. A patch is labeled background and discarded if ðsðRedÞ +
sðGreenÞ + sðBlueÞÞ=3< 18. The values of the Red, Green, and Blue channels range from 0 to 255. The threshold value of 18 was
selected by adjusting it across several slides. We compute percent TIL values using only the foreground patches (i.e., patches
with tissue). Note the set of patches with tissue includes TIL patches.
TIL%= ðNumber of TIL PatchesÞ=ðNumber of Patches with TissueÞ
The lymphocyte CNN is a semi-supervised CNN, initialized by an unupervised Convolutional Autoencoder (CAE). The CNN and the
CAE are designed to have relatively high resolution input such that one can recognize individual lymphocytes. We have chosen to
apply unsupervised CAE pre-training because many studies have shown that it boosts the performance of the CNN, please refer
to our technical report (Hou et al., 2017). Using the lung adenocarcinoma (LUAD) patches, we empirically showed that the CNN
without pre-training achieved significantly lower area under the curve (AUC). The CAE encodes (compresses) an input image patch
of 503 50 mm2 (1003 100 square pixels, corresponding to 20xmagnification) into several vectors of length 100, and then reconstruct
the input image patch using these encoding vectors. We train the CAE in an unsupervised fashion, to minimize the pixel-wise image
patch reconstruction error, with limited number of encoding vectors. By doing this, the CAE implicitly learns to encode the position,
appearance and morphology etc. of nuclei, in the encoding vectors. Our guideline of designing the architecture of the CAE
is that, each encoding vector, in the ideal case, should be capable of encoding one and only one nucleus. As a result, the CAE
has 13 encoding layers and 3 pooling layers. The lymphocyte CNN is built based on the trained CAE: we discard the decoding
(reconstruction) part of the CAE, and added several more layers on the encoding vectors. Therefore, our lymphocyte CNN is a
18-layer network with 14 convolutional layers, 3 pooling layers, and 1 fully connected layer (Zhao et al., 2017).
We use two different CNNs for classification of necrosis regions and TILs, because our experiments showed necrosis regions and
lymphocytes are best recognized and classified at different image scales. The necrosis CNN model performs best with larger input
tissue regions, whereas the lymphocyte CNNmodel achieves the best results with local, high-resolution image patches. The necrosis
segmentation CNN is used to eliminate false positives from the lymphocyte CNN in necrotic regions. In these regions, nuclei mayCell Reports 23, 181–193.e1–e7, April 3, 2018 e2
have characteristics similar to those in lymphocyte infiltrated regions. Because recognizing a region of 503 50 mm2 need contextual
information in a larger region, we model this as a segmentation problem with larger input patches at a relatively lower resolution:
500 3 500 mm2 patches are extracted from the image and downsampled 3 times. The resulting patch is 333 3 333 pixels at
20x magnification. The necrosis segmentation CNN outputs pixel-wise segmentation results. We use DeconvNet (Noh et al.,
2015) for this task because it is designed to predict pixel-wise class labels and handle structures and objects atmultiple scales (which
is more suitable for segmentation than patch-level classification) and it has been shown to achieve high prediction accuracy with
several benchmark image datasets. We train DeconvNet to classify each pixel as inside or outside a necrosis region. The output
of the necrosis segmentation CNN is resized to match the output resolution of the lymphocyte CNN. If over half of a 50x50 patch
intersects with a necrotic region, the patch is classified as non-lymphocyte-infiltrated.
Convolutional Autoencoder Details
The Convolutional Autoencoder (CAE) contains one branch with a small number of low resolution, dense features maps, and a sec-
ond branch with high resolution, but sparse feature maps The high resolution sparse feature maps are designed to capture fore-
ground objects (e.g., cancer cell nuclei and lymphocytes) - these objects are sparsely distributed in the tissue and contain substantial
high spatial frequency color and texture variability. The network learns foreground feature maps in a ‘‘crosswise sparse’’ manner:
neurons across all feature maps are not activated (output zero) in most feature map locations. Only neurons in a few feature map
locations can be activated. Since the non-activated neurons have no influence in the later decoding layers, the image foreground
is reconstructed using only the non-zero responses in the foreground encoding feature maps. The low resolution dense
feature maps are designed to encode background color and texture of the background. We first model the background (tissue,
cytoplasm etc.) and then extract the foreground that contains nuclei.
The supervised CNN takes the unsupervised encoded features from the unsupervised CAE for classification. We initialize the pa-
rameters in these layers to be the same as the parameters in the CAE. We attach four 1x1 convolutional layers after the foreground
encoding layer and two 3x3 convolutional layers after the background encoding layer. Each added layer has 320 convolutional filters.
We then apply global average pooling on the two branches. The pooled features are then concatenated together, followed by a final
classification layer with sigmoid activation function (Hou et al., 2017).
CNN Training and Testing Details
We train our CAE on the unlabeled dataset, minimizing the pixel-wise root mean squared error between the input images and the
reconstructed images. No regularization loss is deployed. We use stochastic gradient descent with batch size 32, learning rate
0.03 and momentum 0.9, and train the network until convergence (6 epochs).
For the lymphocyte CNN (constructed from the CAE) training, we use stochastic gradient descent with batch size 100, learning rate
0.001, andmomentum 0.985. We train the CNN until convergence (64 epochs) and divide the learning rate by 10 at the 20th, 32th, and
52th epoch. We use sigmoid as the nonlinearity function in the last layer and log-likelihood as the loss function. No regularization loss
is deployed. We apply three types of data augmentation. First, the input images are randomly cropped from a larger image. Second,
the colors of the input images are randomly perturbed. Third, we randomly rotate andmirror the input images.We trained theCAE and
CNN on a single Tesla K40 GPU. During testing phase, we augmented the test patch 24 times and averaged the prediction results.
The CAE and CNN used the Theano library (http://deeplearning.net/software/theano/).
CNN-VGG Comparison Experiment Details
We fine-tuned the VGG 16-layer network which was pre-trained on ImageNet. Fine-tuning the VGG16 network has been shown to be
robust for pathology image classification (Xu et.al. 2015; Hou et al., 2016b). We used stochastic gradient descent with batch size 32,
learning rate 0.0001, and momentum 0.985. We trained the lymphocyte CNN until convergence (32 epochs). We used the same loss
function and data augmentation method used for the proposed CNN. To match the input size of the VGG16 network, we re-sized the
input patches from 100 3 100 pixels to 224 3 224 pixels. Same as the proposed CNN, during testing phase, we augment the test
patch 24 times and average the prediction results.
Iterative Model Training and Data Labeling
We have implemented an iterative workflow as depicted in Figure S1 in order to train the CNN models. First, an unsupervised image
analysis of WSIs is executed to initialize a CNN model. This model is refined in an iterative process in which CNN predictions are
reviewed, corrected and refined by expert pathologists and the CNN model is re-trained with the updated data in order to improve
its classification performance. After a training phase, the CNN model is applied to patches in the test set. For each test patch, the
lymphocyte CNNproduces a probability of the patch being a lymphocyte-infiltrated patch. The label of the patch is decided by simple
thresholding; if the probability value is above a predefined threshold, the patch is classified as lymphocyte-infiltrated.
Training a fully supervised CNN requires a large number of training instances with ground truth labels. Masci et al. (Masci et al.,
2011) have shown that utilizing unlabeled instances can boost the performance of a CNN. Drawing from those findings, we first
trained an unsupervised Convolutional Auto-Encoder (CAE) to learn the representation of nuclei and lymphocytes in histopathology
images and initialize the lymphocyte CNN (Zhao et al., 2017). In this way, the initial lymphocyte CNNmodel captures the appearance
of histopathology images without supervised training. We initialized the weights of the necrosis segmentation CNN randomlye3 Cell Reports 23, 181–193.e1–e7, April 3, 2018
following the DeconvNet approach. We then trained the CNNs with labeled images. The training phases of the CNNs involve a cross-
validation step to assess prediction performance and avoid overfitting (Hou et al., 2017).
Review and Refinement of CNN Predictions
We developed a web application, called the TIL-Map editor, to support the review and refinement by the pathologists of the tumor-
infiltrating lymphocyte patch predictions and the segmentation of necrotic regions. The TIL-Map editor extends caMicroscope
(Sharma et al., 2014) interface to enable the visualization of patch-level classification labels as a heatmap overlay on a WSI. It is
distributed as part of a suite of tools called QuIP - Quantitative Imaging for Pathology (Saltz et al., 2017). QuIP is an open-source
software systemwhich consists of a suite of integrated data services andweb-based user applications designed for themanagement
and analysis of whole-slide tissue images and indexing and exploration of image features. When using the TIL-Map editor, a user can
interactively visualize, pan, and zoom-in/out of the whole-slide tissue image and interactively pan and zoom around the image, in a
manner similar to various online mapping systems. It display the TIL-Maps, as polygonal overlays that appear over the H&E image.
The intermediate and final TIL Maps are stored in the QuIP FeatureDB, whichmanages and indexes both the imagemetadata and the
TIL classification results. Figure 2B shows an example heatmap along with the TIL-Map editor.
Each patch in a WSI is represented as a rectangle and associated with a classification label and the probability value computed by
the CNN. This information is stored as a data element (document) in FeatureDB and indexed to speed up queries by the TIL-Map
editor to retrieve and display subsets of patches. After classification results for a set of WSIs have been loaded to the database,
a pathologist can use a web browser to view and update the classification results. The pathologist would use the TIL-Map editor
to examine an image, query FeatureDB to retrieve patches visible within the view point and zoom level and display them as a
two-color heatmap. The pathologist can edit the heatmap using the ‘‘Lymphocyte Sensitivity,’’ ‘‘Necrosis Specificity,’’ ‘‘Smooth-
ness’’ sliders in a panel. These slides allow the pathologist to change the threshold value which determines if a patch should be clas-
sified as lymphocyte-infiltrated or not. For finer-grain editing of individual patches or sets of patches, the pathologist can use the
‘‘Markup Edit’’ function to markup specific patches and label them as lymphocyte-infiltrated or not-lymphocyte-infiltrated. The
pathologist can then save the updated patch labels to the database. The updated patch labels are used to retrain the CNN. Changes
to the heatmap are only visible to the user him/herself: multiple users can work independently selecting lymphocyte sensitivity and
making finer-grain editing in the same slide without knowing each other’s editing choices.
In this work, a team of three pathologists from Stony Brook Medicine and MD Anderson Cancer Center reviewed and refined 10 to
20 WSIs in each cancer type using the TIL-Map editor. Each image was assigned to two pathologists. Each pathologist separately
adjusted the ‘‘Lymphocyte Sensitivity,’’ ‘‘Necrosis Specificity,’’ ‘‘Smoothness’’ thresholds and manually edited regions in the images
using the ‘‘Markup Edit’’ tool in order to generate an accurate patch-level classification in the entire image. Depending on the pathol-
ogists consensus, if retraining was needed, the pathologists collaboratively generated a consensus lymphocyte heatmap for each
image. Data from these consensus heatmaps was input back to the lymphocyte CNN in a training step to further improve its
performance.
Determining Lymphocyte Selection Thresholds
The trained lymphocyte and necrosis CNNswas applied to 5455 diagnostic slides available for the 13 TCGA tumor types in the study.
We then determined selection thresholds based on overall probability estimates for each slide to correct for possible slide-specific
bias, in which the CNNwas seen to systematically over or under predicts lymphocytes depending on the overall characteristics of the
whole slide. The process of determining the lymphocyte selection thresholds is shown in Figure S1. The first step is to classify each
slide into categories that reflect whether there is systematic over or under prediction of lymphocytes. To do this. for each slide, ten
patches were sampled from 10 ranges of the lymphocyte CNN’s scores (0.10-0.20, 0.20-0.25, 0.25-0.30, 0.30-0.40, 0.40-0.50,
0.60-0.70, 0.70-0.80, 0.80-0.90, 0.90-1.00). Three pathologists labeled them as lymphocyte infiltrated or not. Based on the number
of labeled lymphocyte/non-lymphocyte patches, each slide was categorized into 1 of 7 groups: Groups A-G, based corresponding to
0,1,2,3-7,8,9, and 10 positive patches respectively. The second step is to select a threshold in each group. In each group, we
randomly selected 8 slides and manually adjusted thresholds for each of them using our visual TIL-Map editor. The threshold of
all slides in one group was set to be the average threshold selected for the eight slides sampled in that group. Note that if we cate-
gorize the slides intomore number of groups, thenwe have tomanually select thresholds formore slides, since per group, ameaning-
ful averaged threshold requires a minimum number of selected thresholds. On the other hand, if we categorize the slides into fewer
groups, the intra-group variance of possible slide-specific biases might be too large. Therefore, we select seven as the number of
groups, striking a balance between efficiency and effectiveness.
Subsequent to processing as described above, incomplete TIL maps or those with failed predictions were removed, and for LUAD
additional manual review was performed to remove TIL maps derived from poor slides, such as those that were out-of-focus or only
partially visible. This resulted in 5202 TIL maps (see Figure S1C, Table S2) for further analysis and distribution. For a number of TCGA
cases, multiple diagnostics slides are available, distinguished by TCGA slide ID barcode suffixes DX1, DX2,., DX13. All cases have
a DX1 diagnostic slide; hence these slides and corresponding TIL maps were used in subsequent correlative analyses. The 5202
slide-derived TIL maps correspond to 4759 TCGA participants and slide IDs with suffix DX1.Cell Reports 23, 181–193.e1–e7, April 3, 2018 e4
Molecular Data Estimates of Immune Response
We used estimates of tumor and immune characteristics derived and made available in (Thorsson et al., 2018). The estimate of TIL
fraction by genomics measurements is obtained as described therein, by multiplying overall leukocyte fraction derived from DNA
methylation with an aggregated proportion of immune-cell fractions within the immune compartment estimated using CIBERSORT
(Newman et al., 2015). The lymphocyte fraction is an aggregation of CIBERSORT estimates of naive and memory B cells, naive,
resting and activated memory CD4 T cells, follicular helper T cells, T regulatory cells, gamma-delta T cells, CD8 T cells, activated
and resting NK cells and plasma cells. To compare with these data with TIL estimates from images, participant and slide barcodes
were restricted to those satisfying the inclusion criteria of the TCGA PanCancer Atlas and Immune Response Working Group. Of the
4705 caseswith characterized TILmap clusters and patterns (see below), 4612were thus available for molecular data integration and
comparison (Table S1, see also Figure S1C, Table S2).
Local Spatial Structure of Immune Infiltrate
We used the APCluster R package (Bodenhofer et al., 2011) to apply the affinity propagation algorithm to obtain local TIL cluster pat-
terns. The affinity propagation approach (Frey and Dueck, 2007) simultaneously considers all data points as potential exemplars (i.e.,
the centers of clusters) from among possible data points. Treating each data point as a node in a network, it recursively transmits real-
valued messages along edges of the network until it finds a good set of exemplars and corresponding clusters. We define the sim-
ilarities between data points (TIL patches) as the negative square Euclidean distance between them. Aside from the similarity matrix
itself, themost important input parameter is the so-called ‘‘input preference’’ which can be interpreted as the tendency of a data sam-
ple to become an exemplar. The function apcluster in the package contains an argument q that allows setting the ‘input preference’
parameter to a certain quantile of the input similarities: resulting in the median for q = 0.5 and in the minimum for q = 0. To select this
parameter, we generated synthetic data points in a plane comprising two distinct Gaussian clouds of points. Using the synthetic data,
we observed that q = 0 was best able to cluster these points into two clusters, and used this value for identifying TIL clusters. Of the
5202 TIL maps, 5144 clustering results were generated (see Figure S1C, Table S2), with the remainder failing to complete clustering
runs in time or failing due to memory errors, mostly in slides with numerous TILs.
Cluster characterization was made using simple measures of counts and membership and cluster indices from the R package
clusterCrit by Bernard Desgraupes. The Ball-Hall, Banfield-Raftery, C Index, and Determinant Ration indices are detailed in the pack-
age documentation.Variable Definition or Reference
Number of TIL Patches TIL patch count
TIL fraction (TIL patch count)/(Total number of available patches on tissue slice)
Number of TIL Clusters Number of clusters, from affinity propagation clustering
Cluster Size Mean Mean of the cluster membership counts
Cluster Size Standard Deviation Standard deviation of the cluster membership counts
Within-Cluster Dispersion Mean Mean of the values of WGSSk, the within-cluster dispersion (see below)
Within-Cluster Dispersion Standard
Deviation
Standard deviation of the values of WGSSk
Cluster Extent Mean Mean of the maximum distances to clusters exemplars. The cluster examplar is the most
representative TIL patch for the cluster, as defined in the affinity propagation method
Cluster Extent Standard Deviation Standard deviation of the maximum distances to exemplars
Ball Hall Index Ball and Hall (1965). Available at: http://www.dtic.mil/docs/citations/AD0699616
Banfield Raftery Index Banfield and Raftery (1993)
C Index Hubert and Schultz (1976)
Determinant Ratio Index Scott and Symons (1971)
Ball Hall Index - TIL count adjusted ‘Adjusted’ refers to the residual of the corresponding index after regression against %TIL density
Banfield Raftery Index - TIL count
adjusted
‘Adjusted’ refers to the residual of the corresponding index after regression against %TIL density
C Index - TIL count adjusted ‘Adjusted’ refers to the residual of the corresponding index after regression against %TIL density
Determinant Ratio Index - TIL count
adjusted
‘Adjusted’ refers to the residual of the corresponding index after regression against %TIL densityIn the above, WGSSk is a within-cluster dispersion which is the sum of the squared distances between the observations and the
barycenter of the cluster (see https://CRAN.R-project.org/package=clusterCrit) for details. To compute the adjusted indices, linear
regression was used to model the relationship between the clustering index and the%TIL density. The regression residual was usede5 Cell Reports 23, 181–193.e1–e7, April 3, 2018
as the adjusted index. Cluster characteristic were generated for all 5144 slides with cluster results (4705 with DX1 suffix)(see Fig-
ure S1C, Table S2) and adjusted indices for 4509 cases.
Assessment of TIL Map Structural Patterns
In order to perform a comprehensive assessment of the TIL map structural patterns, the collection of 5202 H&E images (see above,
4759 with DX1 suffix) and the corresponding TIL maps were visually inspected to ensure that each H&E image had a correctly
matched TIL map, after which, a subset of 500 H&E images and corresponding TIL maps were closely inspected at higher power
magnification (100x to 200x) in 30-50 fields to ensure that the lymphocyte-detection algorithm was performing as intended and
not mistakenly identifying tumor cells as lymphocytes across the various tumor types as a quality-control measure. We further em-
ployed H&E images and corresponding TILmaps from cases of uveal melanoma as negative controls becausemelanoma tumor cells
and melanotic pigment can be a difficult challenge for the lymphocyte-detection algorithm.
After the negative controls were verified and quality measures were satisfactorily addressed, TIL maps (total N = 4455) were as-
sessed in a two part fashion by a qualitative description and a semiquantitative score based on visual inspection with respect to the
tumor region only, which is determined by histopathologic evaluation at low-power magnification (40x) of the corresponding H&E
diagnostic whole-slide image. The tumor region represents the combined intra-tumoral and peri-tumoral regions and excludes
the adjacent non-tumor regions.
The qualitative description characterizes the nature of the immune infiltrate with respect to the gross spatial distribution of the TILs
in only the tumor region with terms like ‘‘Focal’’ (localized), ‘‘Multi-focal’’ (loosely scattered), ‘‘Diffuse’’ (spread out over a large area),
and ‘‘Band-like’’ (well-defined boundaries bordering the tumor at its periphery). The semiquantitative scoring evaluates the relative
strength of the immune response terms like ‘‘None,’’ ‘‘Non-brisk’’ (minimal tomild partial immune response), and ‘‘Brisk’’ (moderate to
strong immune response).
Taken together, ‘‘Non-brisk, focal’’ is indicative of a ‘‘very weak’’ but minimally present immune response with a low density of TILs
in a localized area of the tumor, whereas ‘‘Non-brisk, multi-focal’’ is indicative of a weak partial immune response with loosely scat-
tered TILs in a few areas of the tumor. However, ‘‘Brisk, diffuse’’ represents a moderate to strong immune response with a relatively
dense and spread out pattern of TILs across > 30% of the tumor even if there are band-like boundaries bordering the tumor at its
periphery. The ‘‘Brisk, band-like’’ description was reserved for cases where the TIL map patterns showed relatively organized struc-
tures that appear as boundaries bordering the tumor at its periphery and < 30% TILs in the intra-tumoral component. ‘‘None’’ was
selected in cases where few TILs were present in less than 1% of the area of the tumor and ‘‘Indeterminate’’ was used if there was
insufficient or no grossly identifiable tumor in the H&E image at low-power with the corresponding TIL map regardless of pattern and
semiquantitative distribution of TILs.Summary Table of Criteria Used to Characterize TIL Map Structural Patterns
Category Immune Response Qualitative Pattern Proportion of Tumor composed of Lymphocytes
Indeterminate Insufficient and/or no tumor in the
H&E image at low-power
Not applicable Not applicable
None No response No pattern <1% TILs
Non-brisk, focal Very Weak (minimal) Localized <5% TILs
Non-brisk, multi-focal Weak (mild) Loosely scattered foci >5%-30% TILs
Brisk, diffuse Moderate to Strong Diffuse and dense infiltrate >30% TILs in the intra-tumoral component*
Brisk, band-like Not applicable Infiltrate bordering the tumor
at its periphery
<30% TILs in the intra-tumoral component*
*If the TIL map patterns revealed both diffuse and band-like immune responses, the predominant pattern was characterized and the difference
between ‘‘Brisk, diffuse’’ and ‘‘Brisk, band-like’’ was based on whether the relative distribution of TILs in the intra-tumoral component appeared to
be greater than or less than 30%, respectively.DATA AND SOFTWARE AVAILABILITY
The original H&E stained whole-slide images used in this work can be downloaded from the Genomic Data Commons. All TCGAmo-
lecular data can be obtained from the Genomic Data Commons, as well as derived data matrices of the PanCancer Atlas. Integration
with immune signatures of the TCGA immune response working group is available through CRI iAtlas web resource. Links to these
data resources can be found at the accompanying publication manuscript page (https://gdc.cancer.gov/about-data/publications/
tilmap).
The analysis codes used in this work is version controlled has also been containerized and made available as a Docker image. The
QuIP software for iterative refinement of CNNprediction results is also available. The training datasets for theCNNmodels and the TILCell Reports 23, 181–193.e1–e7, April 3, 2018 e6
maps generated in this study are also available for download. These different software resources aswell as the TILmaps are available
on the Cancer Imaging Archive, at: https://doi.org/10.7937/K9/TCIA.2018.Y75F9W1
QUANTIFICATION AND STATISTICAL ANALYSIS
The statistical details of all experiments are reported in the text, figure legends and figures, including statistical analysis performed,
statistical significance and counts.e7 Cell Reports 23, 181–193.e1–e7, April 3, 2018
